FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020.

ROCHE HOLDING AG-BR and partner ELI LILLY & CO secured United States regulatory clearance for an Alzheimer's blood test. The Elecsys pTau217 biomarker test targets patients aged 55 and older with cognitive decline.